Vanguard Group Inc Gossamer Bio, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GOSS
# of Institutions
116Shares Held
153MCall Options Held
793KPut Options Held
528K-
Octagon Capital Advisors LP New York, NY18.4MShares$24 Million3.68% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$23.7 Million1.16% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL8.81MShares$11.5 Million0.03% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$10.6 Million4.56% of portfolio
-
683 Capital Management, LLC New York, NY6.98MShares$9.14 Million0.45% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $123M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...